Exicure, Inc. (XCUR) P/E Ratio History
Historical price-to-earnings valuation from 2023 to 2023
Loading P/E history...
XCUR Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Exicure, Inc. (XCUR) trades at a price-to-earnings ratio of -2.1x, with a stock price of $3.35 and trailing twelve-month earnings per share of $-1.46.
The current P/E is 132% below its 5-year average of 6.6x. Over the past five years, XCUR's P/E has ranged from a low of 2.1x to a high of 12.8x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, XCUR trades at a 109% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, XCUR trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our XCUR DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
XCUR P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $74B | 17.1Lowest | 2.70Best | +8%Best |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
XCUR Historical P/E Data (2023–2023)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2023 Q3 | Sat Sep 30 2023 00:00:00 GM | $3.60 | $1.75 | 2.1x | -69% |
| FY2023 Q2 | Fri Jun 30 2023 00:00:00 GM | $6.55 | $1.32 | 5.0x | -25% |
| FY2023 Q1 | Fri Mar 31 2023 00:00:00 GM | $4.36 | $0.34 | 12.8x | +94% |
Average P/E for displayed period: 6.6x
See XCUR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs XCUR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare XCUR vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonXCUR — Frequently Asked Questions
Quick answers to the most common questions about buying XCUR stock.
Is XCUR stock overvalued or undervalued?
XCUR trades at -2.1x P/E, below its 5-year average of 6.6x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does XCUR's valuation compare to peers?
Exicure, Inc. P/E of -2.1x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.
What is XCUR's PEG ratio?
XCUR PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2023-2023.